Acute Porphyria Drugs

R01AD11 - Triamcinolone

Not porphyrinogenic
NP

Rationale
Insignificant systemic exposure . Several references stating non-porphyrinogenicity of glucocorticoids.
Chemical description
Glucocorticoide nasal spray with very low bioavailability. EPI-list: safe South African list: use Kalman, Bonkowski: safe The Merck Manual: safe Tschudy DP, Lamon JM: Porphyrin metabolism and the porphyrias, in Bondy PK, Rosenberg LE (eds.): Duncan's Diseases of Metabolism. Philadelphia, WB Saunders, 1980, p939: safe Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997: safe
Similar drugs
Explore alternative drugs in similar therapeutic classes R01A / R01AD or go back.
References
# Citation details PubMed ID
1. Management of acute attacks in the porphyrias.
Kalman DR, Bonkovsky HL. Clin Dermatol. 1998; 16(2):299-306.
9554242
2. Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
9074793
Other sources
3. Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
Tradenames

Nasacort Nasacort Nasacort Nasacort Nasacort Triamcinolon Nasacort · Nasacort Allergy Nasacort · Triamcinolone Nasacort Nasacort Allespray Nasacort · Telnase Nasacort · Triamcinolone Nasacort · Trinas Nasacort Nasacort · Triamcinolone Triamcinolone Nasacort Nasacort
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙